Abstract
IntroductionDespite a growing body of scholarly research on the risks of severe COVID-19 associated with diabetes, hypertension and obesity, there is a need for estimating pooled risk estimates with adjustment for confounding effects. We conducted a systematic review and meta-analysis to estimate the pooled adjusted risk ratios of diabetes, hypertension and obesity on COVID-19 mortality.MethodsWe searched 16 literature databases for original studies published between 1 December 2019 and 31 December 2020. We used the adapted Newcastle-Ottawa Scale to assess the risk of bias. Pooled risk ratios were estimated based on the adjusted effect sizes. We applied random-effects meta-analysis to account for the uncertainty in residual heterogeneity. We used contour-funnel plots and Egger’s test to assess possible publication bias.ResultsWe reviewed 34 830 records identified in literature search, of which 145 original studies were included in the meta-analysis. Pooled adjusted risk ratios were 1.43 (95% CI 1.32 to 1.54), 1.19 (95% CI 1.09 to 1.30) and 1.39 (95% CI 1.27 to 1.52) for diabetes, hypertension and obesity (body mass index ≥30 kg/m2) on COVID-19 mortality, respectively. The pooled adjusted risk ratios appeared to be stronger in studies conducted before April 2020, Western Pacific Region, low- and middle-income countries, and countries with low Global Health Security Index scores, when compared with their counterparts.ConclusionsDiabetes, hypertension and obesity were associated with an increased risk of COVID-19 mortality independent of other known risk factors, particularly in low-resource settings. Addressing these chronic diseases could be important for global pandemic preparedness and mortality prevention.PROSPERO registration numberCRD42021204371.
Funder
UK Medical Research Council and Wellcome
NIHR
UK National Institute for Health and Care Research
UK Office for National Statistics
UK Biobank
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference88 articles.
1. World Health Organization . Weekly epidemiological update on COVID-19 - 1 February. 2023. Available: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---1-february-2023 [Accessed 1 2023].
2. Mahamat-Saleh Y , Fiolet T , Rebeaud ME , et al . Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open 2021;11:e052777. doi:10.1136/bmjopen-2021-052777
3. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis;Schlesinger;Diabetologia,2021
4. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence;Treskova-Schwarzbach;BMC Med,2021
5. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19;Shah;Acta Diabetol,2021